openPR Logo
Press release

Investigation announced for Investors who lost money with shares in Orthofix Medical Inc. (NASDAQ: OFIX)

09-27-2023 06:13 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Orthofix Medical Inc. (NASDAQ: OFIX) shares over potential securities laws violations.

An investigation for investors in Orthofix Medical Inc. (NASDAQ: OFIX) shares over potential securities laws violations.

An investigation was announced for investors of Orthofix Medical Inc. (NASDAQ: OFIX) shares over potential securities laws violations by Orthofix Medical Inc.

Investors who purchased shares of Orthofix Medical Inc. (NASDAQ: OFIX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Orthofix Medical Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Lewisville, TX based Orthofix Medical Inc. operates spine and orthopedics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. Orthofix Medical Inc. reported that its annual Total Revenue declined from $464.47 million in 2021 to $460.71 million in 2022, and that its Net Loss declined from $25.54 million in 2021 to $19.74 million in 2022.

On September 12, 2023, Orthofix Medical Inc. announced the termination of its CEO, CFO, and CLO. The Company stated, "The Board's decision follows an investigation conducted by independent outside legal counsel and directed and overseen by the Company's independent directors. As a result of the investigation, the Board determined that each of these executives engaged in repeated inappropriate and offensive conduct that violated multiple code of conduct requirements and was inconsistent with the Company's values and culture. These matters are unrelated to and do not impact the Company's strategy, results of operations or previously filed financial statements."

Shares of Orthofix Medical Inc. (NASDAQ: OFIX) declined from $21.60 per share on August 31, 2023, to as low as $12.26 per share on September 22, 2023.

Those who purchased shares of Orthofix Medical Inc. (NASDAQ: OFIX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors who lost money with shares in Orthofix Medical Inc. (NASDAQ: OFIX) here

News-ID: 3225996 • Views:

More Releases from Shareholders Foundation

Investigation announced for Investors in Treace Medical Concepts, Inc. (NASDAQ: TMCI) over potential Wrongdoing
Investigation announced for Investors in Treace Medical Concepts, Inc. (NASDAQ: …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Treace Medical Concepts, Inc. Investors who purchased shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Treace Medical Concepts, Inc. directors breached their fiduciary duties and caused damage to the company and its
Deadline on May 20th coming up in Lawsuit for Investors in the Chemours Company (NYSE: CC)
Deadline on May 20th coming up in Lawsuit for Investors in the Chemours Company …
A deadline is coming up on May 20, 2024 in the lawsuit filed for certain investors of The Chemours Company (NYSE: CC) over alleged securities laws violations by The Chemours Company. Investors who purchased shares of The Chemours Company (NYSE: CC) have certain options and there are strict and short deadlines running. Deadline: May 20, 2024. NYSE: CC stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Lawsuit filed for certain Investors who lost money with shares of Global Cord Blood Corporation (OTC: CORBF)
Lawsuit filed for certain Investors who lost money with shares of Global Cord Bl …
An investor, who purchased shares of Global Cord Blood Corporation (OTC: CORBF), filed a lawsuit over alleged violations of Federal Securities Laws by Global Cord Blood Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Global Cord Blood Corporation (OTC: CORBF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 24, 2024. OTC: CORBF investors should contact the Shareholders
Lawsuit filed for Investors who lost money with shares of Autodesk, Inc. (NASDAQ: ADSK)
Lawsuit filed for Investors who lost money with shares of Autodesk, Inc. (NASDAQ …
An investor, who purchased shares of Autodesk, Inc. (NASDAQ: ADSK), filed a lawsuit over alleged violations of Federal Securities Laws by Autodesk, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Autodesk, Inc. (NASDAQ: ADSK) have certain options and for certain investors are short and strict deadlines running. Deadline: June 24, 2024. NASDAQ: ADSK investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)

All 5 Releases


More Releases for Orthofix

Spinal Implants Market Dynamics 2028 | Orthofix International N.V.
Global Spinal Implants Market: Overview Rapidly growing population and significantly increase in the treatment rate of degenerative spine disorders are the key factors driving demand in the global spinal implants market. Changing the lifestyle that led to the growth of obesity among the masses has further augmented growth for spinal implants. Increasing spine injuries due to increasing sports activities and other reasons are also benefitting growth in this market. Moreover, the
Radiolucent Wrist Fixator Market 2018 - 2028 | Orthofix, Stryker, Smith & Nephew
Market Outlook External fixation devices have been used since a long time. However, these external fixation devices have a number of drawbacks such as risk of infection, stiffness of the joint, discomfort due to weight and hindrance in X-Ray for monitoring the heeling progress. The radiolucent wrist fixators help in reducing the bulk as they are lighter making them a convenient option for patients. External fixation devices can be used for
Medical Bionic Implant Market to 2019 – 2024: Opportunity & Growth Analysis by …
A fresh report has been added to the wide database of Business Industry Reports. The research study is titled “Medical Bionic Implant Market” by Manufacturers, Countries, Type and Application, Forecast to 2024 which provides important data about the production, consumption, revenue and company profiles for key industry participants. Global Medical Bionic Implant Market Synopsis: This report studies the Global Medical Bionic Implant Market over the forecast period of 2019 to 2024. The
Global Orthopedic Devices Market 2019 - Integra LifeSciences, Medtronic, NuVasiv …
Fracture management products include a wide variety of devices including wires, pins, screws, plates, spinal fixation devices, and artificial ligaments. Other orthopedic medical devices include other reconstructive implants, arthroscopy products, electrical stimulation products, and casting products. Get Free Sample Copy of Report Here: http://bit.ly/2FBnsQw Scope of the Report: This report focuses on the Orthopedic Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report
Global Orthobiologics Market 2019 - NuVasive, Stryker, Zimmer, Orthofix
Orthobiologics are substances that orthopaedic surgeons use to help injuries heal more quickly. They are used to improve the healing of broken bones and injured muscles, tendons, and ligaments. These products are made from substances that are naturally found in your body. Get Free Sample Copy of Report Here: http://bit.ly/2FtP7DN Scope of the Report: This report focuses on the Orthobiologics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle
Global Medical Instrument Kits Market 2018 - Arthrex, Biomet, Orthofix, Stryker, …
The statistical surveying information incorporated into the Medical Instrument Kits report is the aftereffect of significant essential and optional research exercises. The report fragments the global Medical Instrument Kits market based on makers, item compose, applications, and regions. In this report, each fragment is contemplated completely and measurements are introduced in detail. The report offers an exact outline of the global Medical Instrument Kits advertise covering key factors, for example,